Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

A Comparative study on the cost effectiveness of intervention of noncommunicable disease in south Darfur 2017

Breadcrumb

  • Home
  • A Comparative study on the cost effectiveness of intervention of noncommunicable disease in south Darfur 2017

Yousif Adam Hussien Noreldin 1 and Ekram Adam Eldoom 2, *

1 RH/GBV Program Analyst Team Leader UNFPA South and East Darfur states 0912321229.
2 Faculty of Public Health, University of Alzaeim Alazhari, Sudan.
 
Research Article
Magna Scientia Advanced Biology and Pharmacy, 2021, 02(01), 019–025
Article DOI: 10.30574/msabp.2021.2.1.0012
DOI url: https://doi.org/10.30574/msabp.2021.2.1.0012
Received on 26 February 2021; revised on 30 March 2021; accepted on 03 April 2021
 
Background: This study conducted to assess the cost effectiveness of common interventions used to control Noncommunicable diseases in south Darfur. Noncommunicable diseases are becoming an increasing public health concern due to their economic significance, and their great impact on the ability of affected individuals to contribute to their communities, and the high burden it represents on the health system.
 Objectives: To evaluate the role of health insurance fund in controlling Noncommunicable diseases. To assess cost effectiveness of the management of Noncommunicable disease within the National Health insurance fund system.
Methods: This study is designed to use secondary data from the national health insurance fund in south Darfur, comparing the cost for the management of 3 selected Noncommunicable diseases (Hypertension, Heart disease, and Diabetes). I have reviewed the entire data of the year 2017 and compared the cost effectiveness of the currently used interventions against health promotion and coordinated approach within the national health insurance fund.
Results: The 3 selected disease (Heart Disease, Hypertension and Diabetes) has significant burden on the health system, both financially and operationally. The NHIF concentrates on the management of Noncommunicable diseases without paying due attention to the importance of prevention strategies such as health promotion, community based integrated management of NCDs, and coordination among other sectors.
Conclusion: To effectively reduce the financial burden of Noncommunicable disease; the NHIF needs to concentrate on prevention of Noncommunicable diseases through extensive health promotion campaigns, promotion of healthy lifestyle, and coordinated approach to controlling Noncommunicable disease.
 
Noncommunicable; Hypertension; Cardiovascular; Diabetes; Renal Disease
 
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2021-…

Preview Article PDF

Yousif Adam Hussien Noreldin and Ekram Adam Eldoom. A Comparative study on the cost effectiveness of intervention of noncommunicable disease in south Darfur 2017. Magna Scientia Advanced Biology and Pharmacy, 2021, 2(1), 019-025. Article DOI: https://doi.org/10.30574/msabp.2021.2.1.0012

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution